Dmed Biopharmaceutical Co., Ltd. Dba Caidya

Dmed Biopharmaceutical Co., Ltd. Dba Caidya company information, Employees & Contact Information

dMed is Now Caidya! Caidya is a global, multi-therapeutic clinical research organization (CRO) dedicated to advancing healthcare innovation and accelerating the development of new therapies. With full-service capabilities and a strategic footprint in 23 countries and regions, our global network provides broad access to diverse patient populations across the Americas, Europe, and APAC. Caidya’s in-depth therapeutic and operational expertise helps partners conduct studies with greater efficiency and confidence. Our commitment to excellence and data-driven decision-making ensures the highest quality standards across all phases of the drug development process. Caidya provides comprehensive clinical trial services from regulatory strategy and submissions, clinical operations, biometrics, and quality management, through post-approval surveillance. Following the merger of dMed and Clinipace, Caidya launched with a clear purpose to liberate clinical research and bring life-changing therapies to our global community.

Company Details

Employees
170
Founded
-
Address
Morrisville, Nc 27560, Us
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Morrisville, NC
Looking for a particular Dmed Biopharmaceutical Co., Ltd. Dba Caidya employee's phone or email?

Dmed Biopharmaceutical Co., Ltd. Dba Caidya Questions

News

Challenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs - British Pharmacological Society | Journals

Challenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs British Pharmacological Society | Journals

dMed raises nearly US$50 million in Series B financing to strengthen and expand its clinical operations capability and global infrastructure - PR Newswire

dMed raises nearly US$50 million in Series B financing to strengthen and expand its clinical operations capability and global infrastructure PR Newswire

Top Dmed Biopharmaceutical Co., Ltd. Dba Caidya Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant